stockrowAnika Therapeutics Inc. (ANIK) vs Glass House Brands Inc. (GLAS)
- Anika Therapeutics Inc. ANIK 19.31 −5.34%
- Glass House Brands Inc. GLAS 2.28 −11.63%
Anika Therapeutics Inc. and Glass House Brands Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $258.7M against $172.7M — 1.5× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −15.4%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −36.2%) and the higher return on invested capital (−3.24% vs −23.4%). Across the 17 metrics below, Anika Therapeutics Inc. leads on 14 and Glass House Brands Inc. on 3.
Valuation
Profitability
| Metric | ANIK | GLAS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.16% | 31.97% | 53.51% |
| Operating margin | (4.24%) | (23.18%) | 0.00% |
| Net margin | (3.14%) | (36.19%) | (2.45%) |
| Free cash flow margin | 0.47% | (20.78%) | 0.00% |
| Return on equity | (2.66%) | (74.02%) | (0.80%) |
| Return on assets | (2.04%) | (19.78%) | (1.67%) |
| Return on invested capital | (3.24%) | (23.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack